Page 41 - Biomarkers for risk stratification and guidance in heart failure

Chapter 2
17. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N. Evaluation of nine automated high-sensitivity c-reactive protein methods: Implications for clinical and epidemiological applications. Part 2. Clinical Chemistry. 2001;47:418
18. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin t and commercial cardiac troponin t and i assays. Clinical Chemistry. 2009;55:101
19. Christenson RH, Duh SH, Wu AHB, Smith A, Abel G, deFilippi CR, Wang S, Adourian A, Adiletto C, Gardiner P. Multicenter determination of galectin-3 assay performance characteristics::: Anatomy of a novel assay for use in heart failure. Clinical biochemistry. 2010;43:683-690
20. Li J, Dunn W, Breaud A, Elliott D, Sokoll LJ, Clarke W. Analytical performance of 4 automated assays for measurement of cystatin c. Clinical Chemistry. 2010;56:1336
21. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE, Jr., Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O’Donnell CJ, Smith SC, Jr., Wilson PW, American Heart Association Expert Panel on Subclinical Atherosclerotic D, Emerging Risk F, the Stroke C. Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the american heart association. Circulation. 2009;119:2408-2416
22. Pencina MJ, D’Agostino RB, Sr., D’Agostino RB, Jr., Vasan RS. Evaluating the added predictive ability of a new marker: From area under the roc curve to reclassification and beyond. Statistics in medicine. 2008;27:157-172; discussion 207-112
23. Steyerberg EW, Harrell FE, Borsboom GJJM, Eijkemans M, Vergouwe Y, Habbema JDF. Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis. Journal of clinical epidemiology. 2001;54:774-781
24. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin t and i among asymptomatic patients with end-stage renal disease. Circulation. 2005;112:3088-3096
25. Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, Angelici L, Barlera S, Parrinello G, Maggioni AP. Prognostic value of very low plasma concentrations of troponin t in patients with stable chronic heart failure. Circulation. 2007;116:1242-1249
26. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL. A sensitive cardiac troponin t assay in stable coronary artery disease. New England Journal of Medicine. 2009;361:2538-2547
27. Lankeit M, Friesen D, Aschoff J, Dellas C, Hasenfuss G, Katus H, Konstantinides S, Giannitsis E. Highly sensitive troponin t assay in normotensive patients with acute pulmonary embolism. Eur Heart J. 2010;31:1836-1844
28. Peacock IV WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Wu AHB. Cardiac troponin and outcome in acute heart failure. New England Journal of Medicine. 2008;358:2117-2126
29. van Wijk S, Jacobs L, Eurlings LW, van Kimmenade R, Lemmers R, Broos P, Bekers O, Prins MH, Crijns HJ, Pinto YM, van Dieijen-Visser MP, Brunner-La Rocca HP. Troponin t measurements by high-sensitivity vs conventional assays for risk stratification in acute dyspnea. Clin Chem. 2011
30. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA. Association of troponin t detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA: the journal of the American Medical Association. 2010;304:2503
31. Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, Feng AN, Young MS, Lin SJ. Independent prognostic value of elevated high-sensitivity c-reactive protein in chronic heart failure. American heart journal. 2004;147:931-938
32. Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, Signorini S, Mocarelli P, Hester A, Glazer R. C-reactive protein in heart failure. Circulation. 2005;112:1428-1434
33. Windram JD, Loh PH, Rigby AS, Hanning I, Clark AL, Cleland JGF. Relationship of high-sensitivity c-reactive protein to prognosis and other prognostic markers in outpatients with heart failure. American heart journal. 2007;153:1048-1055
34. Rehman S, Lloyd-Jones DM, Martinez-Rumayor A, Januzzi Jr JL. Inflammatory markers, amino- terminal pro-brain natriuretic peptide, and mortality risk in dyspneic patients. American journal of clinical pathology. 2008;130:305-311
35. Rehman SU, Martinez-Rumayor A, Mueller T, Januzzi Jr JL. Independent and incremental prognostic value of multimarker testing in acute dyspnea: Results from the probnp investigation of dyspnea in the emergency department (pride) study. Clinica Chimica Acta. 2008;392:41-45
40